You are here: Industry Insights > Bayer

News List

Elsevier/Bayer study findings could cut animal testing pharmatimes
July 13, 2018
A new analysis of safety reporting data by analytics group Elsevier and Bayer has found that some animal tests are far more predictive of human response than others.
Bayer expands Broad Institute partnership to focus on heart failure pharmafile
July 06, 2018
The PCL will be situated at the Massachusetts-based biomedical and genomic research centre. The cardiology lab will leverage new tools and approaches in an effort to gain greater insight into the causes of heart failure while working towards developing me
Bayer to acquire stake in Monsanto India financialexpress
June 14, 2018
Bayer group has launched the process for over ₹ 1,300 crore open offer to acquire up to 26 per cent additional stake in Monsanto India, following global acquisition of the US biotech major for $ 63 billion.
Bayer to acquire stake in Monsanto India financialexpress
June 14, 2018
Bayer group has launched the process for over ₹ 1,300 crore open offer to acquire up to 26 per cent additional stake in Monsanto India, following global acquisition of the US biotech major for $ 63 billion.
Bayer eyes R&D cuts, as Monsanto deal raises question of focus pharmafile
June 07, 2018
When rumours first started rumbling about a mega-merger between Bayer and Monsanto, one of the major question marks was on how this would impact the pharmaceutical side of Bayer’s business.
FDA grants priority review for Bayer, Loxo Oncology's larotrectinib in TRK fusion cancers firstwordpharma
May 30, 2018
Bayer announced Tuesday that the FDA granted priority review to a marketing application submitted by partner Loxo Oncology for larotrectinib to treat adult and paediatric patients with locally advanced or metastatic solid tumours harbouring a neurotrophic
Bayer cuts profit guidance pharmatimes
May 04, 2018
Bayer’s operational business was hit by currency effects in the first quarter of 2018, forcing the company to cut its profit predictions for the year, the company said on Thursday.
Bayer's growth-driving quintet? Better make it a trio, thanks to Stivarga and Xofigo stall fiercepharma
May 04, 2018
Bayer blamed a strong euro for some obvious weak spots in its first-quarter numbers, but that explanation just doesn't fly for its consumer health stall...
Evotec and Bayer Advance Third Endometriosis Programme into Phase I Clinical Development biospace
April 19, 2018
Evotec AGannounced today that its multi-target alliance with Bayer has advanced another promising small molecule into Phase I
Combining tradition with modernity: Bayer hones its brand profile worldpharmanews
April 09, 2018
Dynamic, open, personal: From today forward, these attributes will be the new public face of the Bayer brand. As CEO Werner Baumann explained: "Our brand is our most important distinguishing feature.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page